One study demonstrated the constitutive activation of STAT5 in CTCL; however, in most cases, after blocking the specific Janus kinase, these molecules should not be able to maintain their function in regulating different gene transcriptions [134,135]. This evidence concerns the gene STAT5B and primary cutaneous T-cell non-Hodgkin lymphoma.